Association for Research in Vision and Ophthalmology
Association for Research in Vision and Ophthalmology
April 29, 2019
1 min watch
Save

VIDEO: Wet AMD gene therapy trial shows optimistic results

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

VANCOUVER, British Columbia —Allen C. Ho, MD, of Wills Eye Hospital discusses phase 1/2 data from a clinical trial of a gene therapy treatment candidate for wet age-related macular degeneration at the Association for Research in Vision and Ophthalmology meeting.

The single-dose NAV AAV8 treatment has shown safety in all cohorts and a promising reduction in the need for rescue injections in its third cohort, Ho said.